XML 224 R46.htm IDEA: XBRL DOCUMENT v3.10.0.1
Performance B.4.1. Share-based compensation - Plan awards and shares expected to vest (Details)
$ in Millions
12 Months Ended 24 Months Ended 36 Months Ended 48 Months Ended
Dec. 31, 2018
USD ($)
shares
Dec. 31, 2017
shares
Dec. 31, 2016
shares
Dec. 31, 2015
shares
Dec. 31, 2018
USD ($)
shares
Dec. 31, 2018
USD ($)
shares
Dec. 31, 2018
USD ($)
shares
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Shares issued (in shares) (207,092) (136,047)          
Shares still expected to vest (in shares) 512,211 447,391     512,211 512,211 512,211
2018 Performance Plan              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Initial shares granted (in shares) 237,196            
Additional shares granted (in shares) 0            
Revision for forfeitures (in shares) (13,531)            
Revision for cancellations (in shares) (4,728)            
Total before issuances (in shares) 218,927            
Shares issued (in shares) (97)            
Shares still expected to vest (in shares) 218,830       218,830 218,830 218,830
Estimated cost over the vesting period (US$ millions) | $ $ 12       $ 12 $ 12 $ 12
2018 Deferred Plan              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Initial shares granted (in shares) 262,317            
Additional shares granted (in shares) 3,290            
Revision for forfeitures (in shares) (18,086)            
Revision for cancellations (in shares) 0            
Total before issuances (in shares) 247,521            
Shares issued (in shares) (18,747)            
Shares still expected to vest (in shares) 228,774       228,774 228,774 228,774
Estimated cost over the vesting period (US$ millions) | $ $ 14       $ 14 $ 14 $ 14
2017 Performance Plan              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Initial shares granted (in shares)   279,807          
Additional shares granted (in shares)         2,868    
Revision for forfeitures (in shares)         (34,556)    
Revision for cancellations (in shares)         0    
Total before issuances (in shares)         248,119    
Shares issued (in shares) (2,724) 0          
Shares still expected to vest (in shares) 245,395       245,395 245,395 245,395
Estimated cost over the vesting period (US$ millions) | $ $ 9       $ 9 $ 9 $ 9
2017 Deferred Plan              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Initial shares granted (in shares)   438,505          
Additional shares granted (in shares)         29,406    
Revision for forfeitures (in shares)         (74,325)    
Revision for cancellations (in shares)         0    
Total before issuances (in shares)         393,586    
Shares issued (in shares) (99,399) (2,686)          
Shares still expected to vest (in shares) 291,501       291,501 291,501 291,501
Estimated cost over the vesting period (US$ millions) | $ $ 20       $ 20 $ 20 $ 20
2016 Performance Plan              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Initial shares granted (in shares)     200,617        
Additional shares granted (in shares)           0  
Revision for forfeitures (in shares)           (49,164)  
Revision for cancellations (in shares)           0  
Total before issuances (in shares)           151,453  
Shares issued (in shares) (2,050) (752) (1,214)        
Shares still expected to vest (in shares) 147,437       147,437 147,437 147,437
Estimated cost over the vesting period (US$ millions) | $ $ 8       $ 8 $ 8 $ 8
2016 Deferred Plan              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Initial shares granted (in shares)     287,316        
Additional shares granted (in shares)           0  
Revision for forfeitures (in shares)           (77,924)  
Revision for cancellations (in shares)           0  
Total before issuances (in shares)           209,392  
Shares issued (in shares) (46,039) (43,579) (1,733)        
Shares still expected to vest (in shares) 118,041       118,041 118,041 118,041
Estimated cost over the vesting period (US$ millions) | $ $ 12       $ 12 $ 12 $ 12
2015 Deferred Plan              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Initial shares granted (in shares)       237,620      
Additional shares granted (in shares)             0
Revision for forfeitures (in shares)             (68,121)
Revision for cancellations (in shares)             0
Total before issuances (in shares)             169,499
Shares issued (in shares) (100,630) (30,124) (38,745)        
Estimated cost over the vesting period (US$ millions) | $ $ 12       12 12 $ 12
2015 CEO Plan              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Initial shares granted (in shares)       77,344      
Additional shares granted (in shares)             3,537
Revision for forfeitures (in shares)             0
Revision for cancellations (in shares)             0
Total before issuances (in shares)             80,881
Shares issued (in shares) (26,961) (28,139) (25,781)        
Estimated cost over the vesting period (US$ millions) | $ $ 6       6 6 $ 6
2015 Executive Plan              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Initial shares granted (in shares)       40,664      
Additional shares granted (in shares)             0
Revision for forfeitures (in shares)             0
Revision for cancellations (in shares)             0
Total before issuances (in shares)             40,664
Shares issued (in shares) (19,022) 0 0        
Performance conditions             (21,642)
Estimated cost over the vesting period (US$ millions) | $ $ 2       2 2 $ 2
2015 Performance Plan              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Initial shares granted (in shares)       98,137      
Additional shares granted (in shares)             0
Revision for forfeitures (in shares)             (37,452)
Revision for cancellations (in shares)             0
Total before issuances (in shares)             60,685
Shares issued (in shares) (27,619) (357) (771)        
Performance conditions             (31,938)
Estimated cost over the vesting period (US$ millions) | $ $ 4       $ 4 $ 4 $ 4